Taiwan's Ministry of Health and Welfare launched a medical informatics certification laboratory on August 18, 2026, to develop tests around its FHIR Box health-data integration program. The planned checks cover software, hardware and solution providers, but interoperability does not establish data quality or clinical performance.
A 2025 Science Advances study found that low-dose metformin's glucose-reducing effect in mice depended on a brain Rap1 pathway. The evidence comes from experimental animals, and the parallel for medical AI is limited: a plausible explanation cannot replace external and clinical validation.
Taiwan-based Repurgenesis said in late July 2026 that it had signed a memorandum of understanding with Switzerland-based Medvisis to pursue AI-assisted drug repurposing. The public announcement names a platform and a commercial network, but not a candidate, dataset, validation plan or binding development milestone.
UC San Diego researchers reported on July 8, 2026, that a surgeon remotely controlled a humanoid robot during two gallbladder operations on pigs. The study showed technical feasibility, but human bedside assistance, repeated recalibration and sterility problems remain barriers to clinical use.
Researchers in South Korea and the United States reported two manufacturing advances for stretchable electronics in 2026. One kept liquid-metal conductors working under repeated strain, while the other put a dense computing array on a stretchable patch, but neither study tested a finished implant in people.
A 2026 laboratory study found that freeze-dried platelet-rich plasma could be rehydrated after storage, but it did not test pain relief or tissue repair in patients. Published human evidence for the freeze-dried product remains too limited to borrow treatment claims from conventional platelet-rich plasma.
A July 30, 2026 Coldcard advisory showed how a random-number integration error could remain hidden while security-sensitive outputs still looked valid. The same failure pattern matters in health information systems that generate pseudonyms and SMART on FHIR authorization secrets.
A 2026 Hong Kong cohort study found that speech-response EEG data collected in infancy could help forecast language delay through 32 months of age. The model retained an area under the curve above 0.90 in an independent test set, but it has not been validated across languages or presented as a stand-alone diagnosis.
A 2024 systematic review found that explainable AI increased clinicians' trust in five of 10 empirical studies, while two reported mixed effects. A COVID-19 drug-repurposing project shows how an inspectable workflow can support expert review, but explanations do not establish clinical validity.
